Michael Luebbert
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP) (NCT02717884) | Michael Luebbert | 2015-05-01 |
Track Michael Luebbert automatically
Every clearance here is in the API, with alerts when new ones post.